Literature DB >> 10203085

Prognostic value of MIB-1 index and DNA ploidy in resectable ampulla of Vater carcinoma.

Y M Shyr1, C H Su, L H Wu, A F Li, J H Chiu, C W Wu, W Y Lui.   

Abstract

OBJECTIVE: To evaluate the prognostic value of the proliferative factors, MIB-1 index, DNA ploidy, and S-phase fraction, and further to determine the independent prognostic factors in ampulla of Vater carcinoma after pancreaticoduodenectomy. SUMMARY BACKGROUND DATA: Cell kinetics are important indicators of the biologic behavior of various human tumors, but only a few authors have reported the application of cell proliferative factors in ampulla of Vater carcinoma.
METHODS: Patients undergoing pancreaticoduodenectomy for ampulla of Vater carcinoma were included. Proliferative factors, MIB-1 index, and DNA contents, measured by flow cytometry, were evaluated and compared with the conventional clinicopathologic factors.
RESULTS: Ninety resectable ampulla of Vater carcinomas were included. By univariate analysis, MIB-1 index, DNA ploidy, S-phase fraction, stage, and lymph node status were significant prognostic factors. The 5-year survival rate was 40.7% for tumors with MIB-1 index < or =15% and 0% for those with MIB-1 index >15%. Diploid tumors had a significantly better prognosis than aneuploid. Outcomes of stage I and II tumors were more favorable than those of stage III and IV. After multivariate analysis, MIB-1 index, DNA ploidy, and stage remained as the independent prognostic factors. Among the three independent prognostic factors, MIB-1 index was the most powerful.
CONCLUSIONS: Both MIB-1 index and DNA ploidy provide important prognostic value and potentially complement the conventional prognostic factors in resectable ampulla of Vater carcinoma. MIB-1 index is the most powerful independent prognostic factor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10203085      PMCID: PMC1191738          DOI: 10.1097/00000658-199904000-00011

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  26 in total

1.  Carcinoma of the ampulla of Vater: a tumour with a poor prognosis?

Authors:  R J Farrell; N Noonan; I M Khan; M Goggins; D P Kelleher; P W Keeling
Journal:  Eur J Gastroenterol Hepatol       Date:  1996-02       Impact factor: 2.566

2.  Prognostic significance of the MIB-1 proliferation index for patients with squamous cell carcinoma of the esophagus.

Authors:  E M Youssef; T Matsuda; N Takada; H Osugi; M Higashino; H Kinoshita; T Watanabe; Y Katsura; H Wanibuchi; S Fukushima
Journal:  Cancer       Date:  1995-08-01       Impact factor: 6.860

3.  Quantitative growth fraction evaluation with MIB1 and Ki67 antibodies in breast carcinomas.

Authors:  M Barbareschi; S Girlando; F M Mauri; S Forti; C Eccher; F A Mauri; R Togni; P Dalla Palma; C Doglioni
Journal:  Am J Clin Pathol       Date:  1994-08       Impact factor: 2.493

4.  Prognostic significance of Ki-67 immunostaining in nonmetastatic renal cell carcinoma.

Authors:  W T de Riese; W N Crabtree; E P Allhoff; M Werner; S Liedke; G Lenis; J Atzpodien; H Kirchner
Journal:  J Clin Oncol       Date:  1993-09       Impact factor: 44.544

5.  Carcinoma of the ampulla of Vater.

Authors:  Y L Matory; J Gaynor; M Brennan
Journal:  Surg Gynecol Obstet       Date:  1993-10

6.  Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1.

Authors:  A A Keshgegian; A Cnaan
Journal:  Am J Clin Pathol       Date:  1995-07       Impact factor: 2.493

7.  Comparison of resectable and unresectable periampullary carcinomas.

Authors:  Y M Shyr; C H Su; H C Wang; S S Lo; W Y Lui
Journal:  J Am Coll Surg       Date:  1994-04       Impact factor: 6.113

8.  Prognostic value of ploidy and proliferation markers in renal cell carcinoma.

Authors:  A Tannapfel; H A Hahn; A Katalinic; R J Fietkau; R Kühn; C W Wittekind
Journal:  Cancer       Date:  1996-01-01       Impact factor: 6.860

9.  Prognostic indicators for neuroblastoma: stage, grade, DNA ploidy, MIB-1-proliferation index, p53, HER-2/neu and EGFr--a survival study.

Authors:  L J Layfield; J K Thompson; R K Dodge; B J Kerns
Journal:  J Surg Oncol       Date:  1995-05       Impact factor: 3.454

10.  Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomas.

Authors:  P A Ellis; A Makris; S A Burton; J Titley; M G Ormerod; J Salter; T J Powles; I E Smith; M Dowsett
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

View more
  1 in total

1.  Tumor budding as a strong prognostic indicator in invasive ampullary adenocarcinomas.

Authors:  Nobuyuki Ohike; Ipek Coban; Grace E Kim; Olca Basturk; Takuma Tajiri; Alyssa Krasinskas; Sudeshna Bandyopadhyay; Toshio Morohoshi; Yuki Shimada; David A Kooby; Charles A Staley; Michael Goodman; N Volkan Adsay; Nazmi Volkan Adsay
Journal:  Am J Surg Pathol       Date:  2010-10       Impact factor: 6.394

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.